130 related articles for article (PubMed ID: 25790258)
1. Radiation therapy may increase metastatic potential in alveolar rhabdomyosarcoma.
Woods GM; Bondra K; Chronowski C; Leasure J; Singh M; Hensley L; Cripe TP; Chakravarti A; Houghton P
Pediatr Blood Cancer; 2015 Sep; 62(9):1550-1554. PubMed ID: 25790258
[TBL] [Abstract][Full Text] [Related]
2. The application of radiation therapy to the Pediatric Preclinical Testing Program (PPTP): results of a pilot study in rhabdomyosarcoma.
Kaplon R; Hadziahmetovic M; Sommerfeld J; Bondra K; Lu L; Leasure J; Nguyen P; McHugh K; Li N; Chronowski C; Sebastian N; Singh M; Kurmasheva R; Houghton P; Pelloski CE
Pediatr Blood Cancer; 2013 Mar; 60(3):377-382. PubMed ID: 22692929
[TBL] [Abstract][Full Text] [Related]
3. NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance.
Marampon F; Codenotti S; Megiorni F; Del Fattore A; Camero S; Gravina GL; Festuccia C; Musio D; De Felice F; Nardone V; Santoro AN; Dominici C; Fanzani A; Pirtoli L; Fioravanti A; Tombolini V; Cheleschi S; Tini P
J Cancer Res Clin Oncol; 2019 Apr; 145(4):881-893. PubMed ID: 30701326
[TBL] [Abstract][Full Text] [Related]
4. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
[TBL] [Abstract][Full Text] [Related]
5. Effects of standard chemotherapy on tumor growth and regulation of multidrug resistance genes and proteins in childhood rhabdomyosarcoma.
Seitz G; Warmann SW; Vokuhl CO; Heitmann H; Treuner C; Leuschner I; Fuchs J
Pediatr Surg Int; 2007 May; 23(5):431-9. PubMed ID: 17211591
[TBL] [Abstract][Full Text] [Related]
6. Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization.
Petragnano F; Pietrantoni I; Camero S; Codenotti S; Milazzo L; Vulcano F; Macioce G; Giordani I; Tini P; Cheleschi S; Gravina GL; Festuccia C; Rossetti A; Delle Monache S; Ordinelli A; Ciccarelli C; Mauro A; Barbara B; Antinozzi C; Schiavetti A; Maggio R; Di Luigi L; Polimeni A; Marchese C; Tombolini V; Fanzani A; Bernabò N; Megiorni F; Marampon F
J Biomed Sci; 2020 Aug; 27(1):90. PubMed ID: 32854690
[TBL] [Abstract][Full Text] [Related]
7. The over-expression of cell migratory genes in alveolar rhabdomyosarcoma could contribute to metastatic spread.
Rapa E; Hill SK; Morten KJ; Potter M; Mitchell C
Clin Exp Metastasis; 2012 Jun; 29(5):419-29. PubMed ID: 22415709
[TBL] [Abstract][Full Text] [Related]
8. MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells.
Cassandri M; Pomella S; Rossetti A; Petragnano F; Milazzo L; Vulcano F; Camero S; Codenotti S; Cicchetti F; Maggio R; Festuccia C; Gravina GL; Fanzani A; Megiorni F; Catanoso M; Marchese C; Tombolini V; Locatelli F; Rota R; Marampon F
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639012
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation.
Codenotti S; Faggi F; Ronca R; Chiodelli P; Grillo E; Guescini M; Megiorni F; Marampon F; Fanzani A
Cancer Lett; 2019 May; 449():135-144. PubMed ID: 30771426
[TBL] [Abstract][Full Text] [Related]
10. Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: focus on MYCN as a biologically relevant target.
Mercado GE; Xia SJ; Zhang C; Ahn EH; Gustafson DM; Laé M; Ladanyi M; Barr FG
Genes Chromosomes Cancer; 2008 Jun; 47(6):510-20. PubMed ID: 18335505
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of miRNAs in rhabdomyosarcoma and malignant rhabdoid tumor.
Armeanu-Ebinger S; Herrmann D; Bonin M; Leuschner I; Warmann SW; Fuchs J; Seitz G
Exp Cell Res; 2012 Dec; 318(20):2567-77. PubMed ID: 23000453
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous metastasis, proliferation characteristics and radiation sensitivity of fractionated irradiation recurrent and unirradiated human xenografts.
Huang P; Taghian A; Hsu DW; Perez LA; Allam A; Duffy M; DaCosta A; Suit HD
Radiother Oncol; 1996 Oct; 41(1):73-81. PubMed ID: 8961371
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine Induces Apoptosis and Down-regulation of
Ahn EH; Lee MB; Seo DJ; Lee J; Kim Y; Gupta K
Anticancer Res; 2018 Jan; 38(1):71-76. PubMed ID: 29277758
[TBL] [Abstract][Full Text] [Related]
15. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines.
Kouraklis G; Triche TJ; Wesley R; Tsokos M
Pediatr Res; 1999 Apr; 45(4 Pt 1):552-8. PubMed ID: 10203148
[TBL] [Abstract][Full Text] [Related]
16. Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population.
Ciccarelli C; Vulcano F; Milazzo L; Gravina GL; Marampon F; Macioce G; Giampaolo A; Tombolini V; Di Paolo V; Hassan HJ; Zani BM
Mol Cancer; 2016 Feb; 15():16. PubMed ID: 26897742
[TBL] [Abstract][Full Text] [Related]
17. Assessing alveolar rhabdomyosarcoma cell lines as tumor models by comparison of mRNA expression profiles.
Batchu S; Kellish AS; Hakim AA
Gene; 2020 Nov; 760():145025. PubMed ID: 32758582
[TBL] [Abstract][Full Text] [Related]
18. Cetuximab promotes immunotoxicity against rhabdomyosarcoma in vitro.
Herrmann D; Seitz G; Warmann SW; Bonin M; Fuchs J; Armeanu-Ebinger S
J Immunother; 2010 Apr; 33(3):279-86. PubMed ID: 20445348
[TBL] [Abstract][Full Text] [Related]
19. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.
Williamson D; Missiaglia E; de Reyniès A; Pierron G; Thuille B; Palenzuela G; Thway K; Orbach D; Laé M; Fréneaux P; Pritchard-Jones K; Oberlin O; Shipley J; Delattre O
J Clin Oncol; 2010 May; 28(13):2151-8. PubMed ID: 20351326
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin-induced tumor vasculature remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation.
Myers AL; Orr WS; Denbo JW; Ng CY; Zhou J; Spence Y; Wu J; Davidoff AM
J Pediatr Surg; 2012 Jan; 47(1):183-9. PubMed ID: 22244414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
